Pipeline

Developing Cell and Tissue-Based Therapies for a Range of Aesthetic & Medical Conditions

At Bimini Health Tech, we are commercializing and investigating autologous and allogenic products and therapies ready to use at the point of care and eliminate the need to match patients with donors.

Bimini’s products have been successfully used in clinical settings to help hundreds of thousands of patients worldwide. We have products undergoing trials for androgenic alopecia and osteoarthritis of the knee. Bimini is in the early stages of unlocking the full potential of its product portfolio and adipose-derived stem cell technology both in autologous and allogeneic form.

PRODUCT/BRAND MARKET RESEARCH DEVELOPMENT CLEARANCE/APPROVAL
PUREGRAFT FILTRATION SYSTEMS US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
PUREGRAFT SYNC* US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
PUREGRAFT MICROFAT US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN**
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
HEALEON HD PRP US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
HEALEON DUET US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
Serene Breast Implant™ US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN**
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
DERMAPOSE US
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
CE MARK
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL
JAPAN
RESEARCH
DEVELOPMENT
CLEARANCE/APPROVAL

*In development – US only

**Available via physician license

Contact